Michelle

Lofwall

Michelle Lofwall MD is a Professor of Behavioral Science and Psychiatry and the Bell Alcohol and Addictions Chair at the University of Kentucky Center on Drug and Alcohol Research. She is the medical director of the First Bridge outpatient opioid use disorder (OUD) treatment clinic that provides comprehensive care to patients discharging from the emergency room and inpatient medical/surgical services. Her clinical research has been funded by the National Institutes of Health and industry with a focus on OUD, including medication development of long-acting buprenorphine implants and weekly and monthly buprenorphine injections. She was as an expert panel member on SAMHSA’s newly published Substance Treatment Improvement Protocol (TIP 63) for Medication Treatment of OUD, a board member of the American Society of Addiction Medicine, an invited speaker to the National Academy of Medicine and recipient of several medical student teaching and mentorship awards.